Talk to Geoffrey
+1 718 618 4302
Search inside this page
Publication dates
Publishers
data types
Free Market Research Guides to Download
» Purchase Premium Reports
1-12 of 12 reports
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
Summary Tissue Therapies Limited (TTL) is a biomedical technology company, based in Australia. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. ...
Other Immunological Disorders - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Other Immunological Disorders - Pipeline Review, H2 2012', provides an overview of the Other Immunological Disorders ...
Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Tissue Therapies Limited (TTL) is a publicly held Australian based biotechnology company. The company ...
Stem cells are primal cells found in all multi-cellular organisms that retain the ability to renew themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. ...
Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment Summary GBI Research's report, ?Oncology Devices Market ...
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...
This report analyzes the Global market for Lou Gehrig's Disease in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 37 companies including ...
Introduction The Top 20 cancer therapy brands in Australia reached sales of about $545m in 2008, growing at a CAGR of 30% since 2005. Datamonitor forecasts this growth to slow down considerably to a CAGR ...
The industry player products are medical diagnosis, scientific research and line in tube blood incubation step. Cellestis develops and industry s QuantiFERON technology products for medical diagnosis ...
It is engaged in creating, development and commercializing of novel antisense pharmaceuticals. The firm ?s research and development activities are focused on developing antisense drugs. The firm ?s product ...
» Download Public Reports
44 reports
... Relevant to rheumatoid arthritis, Dr french said. Dr french said that by specifically silencing various genes benitec S dna-directed rna interference (ddrnai) technology was capable of modulating stem cells ...
Reportlinker.com © Copyright 2013. All rights reserved.